Flowchart of subjects’ inclusion process. by Herindita Puspitaningtyas (11618232)

Subjects:

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

Multiple miRNAs decrease telomerase activity. by Radmila Hrdličková (523455)

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

BA decreases DUB activity in PC cells. by Teresita Reiner (281437)

“…(<b>B</b>) DUB assay showed that BA treatment of LNCaP cells significantly decreased DUB activity at 24 and 48 h relative to control treated cells ( = 1) (*, <i>P</i><5×10⁻⁵). …”

Decreased expression of CXCR5 on SHIV-specific CD8+ T cells and NK cells after N-803 in lymph nodes. by Gabriela M. Webb (8566788)

Complex I inhibitor decreases ROS level by Zheng Li (26302)

Decreased neutrophils in <i>MiR125a</i>^<i>-/-</i> mice. by Yuting Qin (1950118)

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis. by Wencheng Jin (13136262)

Subjects:

Increased osmolarity decreases the activity of the cytochrome pathways. by Wilson Garcia-Neto (3622400)

VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival. by Aye M. Mon (5714912)

“…The median rank of overexpression is shown by the spectrum of white-pink-red colors shown in the legend; VRK1 is in the top 5% of overexpressed mRNAs in subsets 2,3,6–9 and in the top 10% of overexpressed mRNAs in subsets 5 and 11. …”

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Comparison of estimated arterial cerebral blood volumes (aCBVs) (Mean ± SD^*) between multiphase bSSFP and AVAST (N = 5). by Ki Hwan Kim (427869)

L-sel decreases the number of circulating lymphocytes. by Izabela Rozenberg (214521)

“…<b>F</b>) The number of activated T-cells (CD4⁺CD44⁺) remained unchanged after 6 weeks of HCD (n = 5–7; p = n.s.) and decreased after 12 weeks of HCD (n = 5–7; ^*p<0.05) as compared to control.…”

Reduced expression of Tks5 leads to decreased growth of tumor cells <i>in vitro</i> and <i>in vivo</i>. by Barbara Blouw (715467)

Complex I inhibitor decreases LDH release by Zheng Li (26302)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”

Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

“…<p>(A) The mean ΔBCD curves describe the difference between the treated and untreated lenses from all animals (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010402#s4" target="_blank">Methods and Materials</a>). …”

Fucoidan decreased lung metastases of breast cancer. by Meilan Xue (310911)